|
|
renal system process
|
GO:0003014 |
48 |
0.999
|
|
|
|
hexose transmembrane transport
|
GO:0035428 |
7 |
0.997
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.997
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.994
|
|
|
|
response to osmotic stress
|
GO:0006970 |
21 |
0.993
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.993
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.993
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.992
|
|
|
|
renin angiotensin regulation of aldosterone production
|
GO:0002018 |
3 |
0.991
|
|
|
|
regulation of renal output by angiotensin
|
GO:0002019 |
2 |
0.988
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.981
|
Mouse |
|
|
l amino acid transport
|
GO:0015807 |
32 |
0.979
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.974
|
|
|
|
chloride transport
|
GO:0006821 |
32 |
0.972
|
|
|
|
inorganic anion transport
|
GO:0015698 |
43 |
0.970
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.963
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.963
|
|
|
|
positive regulation of blood pressure
|
GO:0045777 |
21 |
0.962
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.953
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.949
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.945
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.940
|
|
|
|
progesterone metabolic process
|
GO:0042448 |
4 |
0.923
|
|
|
|
carnitine transmembrane transport
|
GO:1902603 |
3 |
0.919
|
|
|
|
fat soluble vitamin catabolic process
|
GO:0042363 |
1 |
0.903
|
|
|
|
c21 steroid hormone biosynthetic process
|
GO:0006700 |
3 |
0.875
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.868
|
|
|
|
renal system process involved in regulation of systemic arterial blood pressure
|
GO:0003071 |
15 |
0.844
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.838
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.835
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.832
|
|
|
|
activation of janus kinase activity
|
GO:0042976 |
2 |
0.822
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.819
|
|
|
|
monovalent inorganic cation homeostasis
|
GO:0055067 |
33 |
0.815
|
|
|
|
urate transport
|
GO:0015747 |
1 |
0.805
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.800
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.798
|
|
|
|
monoamine transport
|
GO:0015844 |
33 |
0.797
|
|
|
|
renal sodium ion transport
|
GO:0003096 |
2 |
0.797
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.783
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.771
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.770
|
|
|
|
amino acid transmembrane transport
|
GO:0003333 |
37 |
0.767
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.765
|
|
|
|
drinking behavior
|
GO:0042756 |
5 |
0.762
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.719
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.718
|
|
|
|
positive regulation of systemic arterial blood pressure
|
GO:0003084 |
9 |
0.717
|
|
|
|
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator
|
GO:1902238 |
1 |
0.708
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.704
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.698
|
|
|
|
inorganic anion transmembrane transport
|
GO:0098661 |
29 |
0.698
|
|
|
|
potassium ion homeostasis
|
GO:0055075 |
4 |
0.692
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.692
|
|
|
|
immune response in mucosal associated lymphoid tissue
|
GO:0002386 |
2 |
0.691
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.690
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.662
|
|
|
|
vitamin d catabolic process
|
GO:0042369 |
1 |
0.661
|
|
|
|
regulation of blood volume by renal aldosterone
|
GO:0002017 |
1 |
0.653
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.650
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.645
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.633
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.632
|
|
|
|
neurotransmitter uptake
|
GO:0001504 |
14 |
0.630
|
|
|
|
regulation of systemic arterial blood pressure by renin angiotensin
|
GO:0003081 |
20 |
0.628
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.626
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.618
|
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.611
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.604
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.595
|
|
|
|
response to vitamin d
|
GO:0033280 |
3 |
0.589
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.585
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.585
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.582
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.580
|
|
|
|
regulation of systemic arterial blood pressure by circulatory renin angiotensin
|
GO:0001991 |
13 |
0.579
|
|
|
|
intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator
|
GO:1990127 |
1 |
0.579
|
|
|
|
histamine uptake
|
GO:0051615 |
1 |
0.577
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.572
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.571
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.570
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.568
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.562
|
|
|
|
regulation of phospholipase a2 activity
|
GO:0032429 |
3 |
0.560
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.559
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.557
|
|
|
|
sodium ion homeostasis
|
GO:0055078 |
7 |
0.551
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.551
|
|
|
|
visual perception
|
GO:0007601 |
52 |
0.548
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.543
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.542
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.537
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.533
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.517
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.511
|
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.510
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.505
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.505
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.501
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.483
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.482
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.481
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.479
|
|
|
|
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator
|
GO:1902239 |
1 |
0.476
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.470
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.464
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.460
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.457
|
|
|
|
mineralocorticoid biosynthetic process
|
GO:0006705 |
1 |
0.454
|
|
|
|
renal response to blood flow involved in circulatory renin angiotensin regulation of systemic arterial blood pressure
|
GO:0001999 |
6 |
0.453
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.451
|
|
|
|
g protein coupled receptor signaling pathway coupled to cgmp nucleotide second messenger
|
GO:0007199 |
1 |
0.447
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.437
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.434
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.432
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.426
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.420
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.419
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.408
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.404
|
|
|
|
negative regulation of blood pressure
|
GO:0045776 |
22 |
0.397
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.396
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.395
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.394
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.386
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.380
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.376
|
Mouse |
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.375
|
|
|
|
response to corticosterone
|
GO:0051412 |
1 |
0.375
|
|
|
|
sensory perception of light stimulus
|
GO:0050953 |
54 |
0.374
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.373
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.371
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.370
|
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.370
|
|
|
|
histamine induced gastric acid secretion
|
GO:0001697 |
1 |
0.361
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.350
|
|
|
|
transcytosis
|
GO:0045056 |
5 |
0.349
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.349
|
|
|
|
vitamin transport
|
GO:0051180 |
10 |
0.339
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.338
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.337
|
|
|
|
potassium ion transport
|
GO:0006813 |
52 |
0.320
|
|
|
|
regulation of inward rectifier potassium channel activity
|
GO:1901979 |
1 |
0.319
|
|
|
|
negative regulation of smooth muscle cell apoptotic process
|
GO:0034392 |
1 |
0.313
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.306
|
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.305
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.303
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.302
|
|
|
|
vitamin catabolic process
|
GO:0009111 |
1 |
0.301
|
|
|
|
catecholamine transport
|
GO:0051937 |
21 |
0.301
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.298
|
|
|
|
c21 steroid hormone metabolic process
|
GO:0008207 |
7 |
0.295
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.289
|
|
|
|
norepinephrine secretion
|
GO:0048243 |
2 |
0.284
|
|
|
|
regulation of potassium ion transport
|
GO:0043266 |
16 |
0.284
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.283
|
|
|
|
alpha amino acid catabolic process
|
GO:1901606 |
18 |
0.280
|
|
|
|
l glutamate transport
|
GO:0015813 |
16 |
0.274
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.271
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.270
|
|
|
|
cell growth involved in cardiac muscle cell development
|
GO:0061049 |
3 |
0.269
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.260
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
49 |
0.257
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.252
|
|
|
|
vitamin d3 metabolic process
|
GO:0070640 |
3 |
0.252
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.248
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.247
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.247
|
|
|
|
intrinsic apoptotic signaling pathway in response to osmotic stress
|
GO:0008627 |
2 |
0.246
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.246
|
|
|
|
renal system process involved in regulation of blood volume
|
GO:0001977 |
4 |
0.244
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.243
|
|
|
|
adult walking behavior
|
GO:0007628 |
41 |
0.241
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.238
|
|
|
|
water transport
|
GO:0006833 |
12 |
0.237
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.234
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.232
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.232
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.231
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.229
|
Mouse |
|
|
dicarboxylic acid transport
|
GO:0006835 |
29 |
0.229
|
|
|
|
excretion
|
GO:0007588 |
22 |
0.228
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.226
|
|
|
|
hexose transport
|
GO:0008645 |
56 |
0.220
|
|
|
|
vasodilation by norepinephrine epinephrine involved in regulation of systemic arterial blood pressure
|
GO:0002025 |
3 |
0.219
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.218
|
Mouse |
|
|
regulation of resting membrane potential
|
GO:0060075 |
3 |
0.218
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.216
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.215
|
Mouse |
|
|
hormone biosynthetic process
|
GO:0042446 |
16 |
0.215
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.214
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.213
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.212
|
|
|
|
metanephric tubule development
|
GO:0072170 |
18 |
0.212
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.212
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.212
|
|
|
|
l glutamate uptake involved in synaptic transmission
|
GO:0051935 |
3 |
0.211
|
|
|
|
positive regulation of blood circulation
|
GO:1903524 |
22 |
0.209
|
|
|
|
metanephric distal convoluted tubule development
|
GO:0072221 |
5 |
0.208
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.208
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.208
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.207
|
|
|
|
regulation of camp mediated signaling
|
GO:0043949 |
7 |
0.203
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.200
|
|
|
|
negative regulation of peptidyl serine phosphorylation
|
GO:0033137 |
10 |
0.199
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.198
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.196
|
|
|
|
regulation of angiotensin levels in blood
|
GO:0002002 |
4 |
0.195
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.195
|
|
|
|
superoxide metabolic process
|
GO:0006801 |
27 |
0.194
|
|
|
|
positive regulation of renal sodium excretion
|
GO:0035815 |
2 |
0.193
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.190
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.190
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.188
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.186
|
|
|
|
catecholamine secretion
|
GO:0050432 |
15 |
0.185
|
|
|
|
cellular response to osmotic stress
|
GO:0071470 |
7 |
0.184
|
|
|
|
regulation of circadian sleep wake cycle sleep
|
GO:0045187 |
3 |
0.184
|
|
|
|
calcitriol biosynthetic process from calciol
|
GO:0036378 |
3 |
0.184
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.183
|
|
|
|
negative regulation of systemic arterial blood pressure
|
GO:0003085 |
15 |
0.183
|
|
|
|
eye photoreceptor cell differentiation
|
GO:0001754 |
41 |
0.183
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.182
|
|
|
|
negative regulation of heart rate
|
GO:0010459 |
4 |
0.181
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
33 |
0.178
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.176
|
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.176
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.175
|
Mouse |
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.173
|
|
|
|
regulation of g protein activated inward rectifier potassium channel activity
|
GO:1900128 |
1 |
0.172
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.170
|
|
|
|
aldosterone metabolic process
|
GO:0032341 |
2 |
0.169
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.168
|
|
|
|
distal tubule development
|
GO:0072017 |
8 |
0.167
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.166
|
|
|
|
g protein coupled acetylcholine receptor signaling pathway
|
GO:0007213 |
4 |
0.164
|
|
|
|
brain renin angiotensin system
|
GO:0002035 |
5 |
0.161
|
|
|
|
regulation of catecholamine secretion
|
GO:0050433 |
12 |
0.160
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.158
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.158
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.158
|
|
|
|
regulation of neurotrophin trk receptor signaling pathway
|
GO:0051386 |
4 |
0.157
|
|
|
|
fluid transport
|
GO:0042044 |
14 |
0.154
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.154
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.154
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.154
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.154
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.154
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.153
|
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.152
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.151
|
|
|
|
steroid biosynthetic process
|
GO:0006694 |
47 |
0.151
|
|
|
|
hydrogen ion transmembrane transport
|
GO:1902600 |
25 |
0.151
|
|
|
|
negative regulation of ion transport
|
GO:0043271 |
28 |
0.150
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.149
|
|
|
|
neurotrophin signaling pathway
|
GO:0038179 |
12 |
0.149
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.149
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.148
|
|
|
|
aldosterone biosynthetic process
|
GO:0032342 |
1 |
0.147
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.147
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.145
|
|
|
|
neuropeptide signaling pathway
|
GO:0007218 |
19 |
0.144
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.144
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.144
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.144
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.143
|
Mouse |
|
|
angiotensin activated signaling pathway
|
GO:0038166 |
4 |
0.142
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.140
|
|
|
|
negative regulation of neurotrophin trk receptor signaling pathway
|
GO:0051387 |
2 |
0.140
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.139
|
|
|
|
renal water homeostasis
|
GO:0003091 |
7 |
0.139
|
|
|
|
metanephric nephron development
|
GO:0072210 |
34 |
0.139
|
|
|
|
physiological cardiac muscle hypertrophy
|
GO:0003301 |
3 |
0.138
|
|
|
|
adenylate cyclase activating g protein coupled receptor signaling pathway
|
GO:0007189 |
30 |
0.138
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
31 |
0.137
|
|
|
|
regulation of the force of heart contraction
|
GO:0002026 |
17 |
0.133
|
|
|
|
response to water deprivation
|
GO:0009414 |
1 |
0.132
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.132
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.131
|
|
|
|
monosaccharide biosynthetic process
|
GO:0046364 |
44 |
0.131
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.131
|
|
|
|
cellular response to monosaccharide stimulus
|
GO:0071326 |
47 |
0.130
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.129
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.126
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.125
|
|
|
|
response to corticosteroid
|
GO:0031960 |
20 |
0.125
|
|
|
|
dibenzo p dioxin metabolic process
|
GO:0018894 |
1 |
0.124
|
|
|
|
glucocorticoid metabolic process
|
GO:0008211 |
9 |
0.123
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.122
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.118
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.118
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.118
|
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.116
|
Mouse |
|
|
telencephalon development
|
GO:0021537 |
186 |
0.116
|
|
|
|
neurological system process involved in regulation of systemic arterial blood pressure
|
GO:0001976 |
18 |
0.116
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.116
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.115
|
|
|
|
g protein coupled receptor signaling pathway involved in heart process
|
GO:0086103 |
4 |
0.111
|
|
|
|
amino acid import into cell
|
GO:1902837 |
4 |
0.111
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.110
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.110
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.109
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.108
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.108
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.107
|
|
|
|
regulation of long term neuronal synaptic plasticity
|
GO:0048169 |
19 |
0.107
|
|
|
|
maternal process involved in female pregnancy
|
GO:0060135 |
32 |
0.106
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.106
|
|
|
|
regulation of neuronal synaptic plasticity
|
GO:0048168 |
30 |
0.104
|
|
|
|
peptide hormone processing
|
GO:0016486 |
9 |
0.103
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.102
|
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
32 |
0.101
|
|
|
|
cellular response to gonadotropin stimulus
|
GO:0071371 |
4 |
0.101
|
|
|
|
regulation of superoxide anion generation
|
GO:0032928 |
4 |
0.100
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.100
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.100
|
|
|
|
amino acid betaine transport
|
GO:0015838 |
3 |
0.099
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.099
|
|
|
|
regulation of cholesterol esterification
|
GO:0010872 |
2 |
0.099
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.098
|
|
|
|
cellular response to carbohydrate stimulus
|
GO:0071322 |
50 |
0.098
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.098
|
|
|
|
response to water
|
GO:0009415 |
1 |
0.098
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.097
|
|
|
|
regulation of steroid biosynthetic process
|
GO:0050810 |
26 |
0.096
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.096
|
|
|
|
renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure
|
GO:0003072 |
5 |
0.096
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.095
|
|
|
|
regulation of steroid metabolic process
|
GO:0019218 |
39 |
0.095
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.095
|
|
|
|
regulation of norepinephrine secretion
|
GO:0014061 |
2 |
0.094
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.094
|
|
|
|
regulation of activation of jak2 kinase activity
|
GO:0010534 |
1 |
0.093
|
|
|
|
intestinal absorption
|
GO:0050892 |
13 |
0.093
|
|
|
|
thick ascending limb development
|
GO:0072023 |
2 |
0.093
|
|
|
|
metanephric ascending thin limb development
|
GO:0072218 |
2 |
0.092
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.092
|
|
|
|
negative regulation of purine nucleotide metabolic process
|
GO:1900543 |
16 |
0.091
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.091
|
|
|
|
response to estrogen
|
GO:0043627 |
24 |
0.090
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.090
|
|
|
|
ascending thin limb development
|
GO:0072021 |
2 |
0.090
|
|
|
|
response to dexamethasone
|
GO:0071548 |
8 |
0.090
|
|
|
|
hormone mediated signaling pathway
|
GO:0009755 |
23 |
0.090
|
|
|
|
phospholipase c activating serotonin receptor signaling pathway
|
GO:0007208 |
1 |
0.090
|
|
|
|
response to phenylpropanoid
|
GO:0080184 |
22 |
0.088
|
|
|
|
forebrain neuron development
|
GO:0021884 |
30 |
0.088
|
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
39 |
0.087
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.087
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.087
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.087
|
|
|
|
dopamine receptor signaling pathway
|
GO:0007212 |
16 |
0.086
|
|
|
|
grooming behavior
|
GO:0007625 |
16 |
0.086
|
|
|
|
amino acid uptake involved in synaptic transmission
|
GO:0051933 |
3 |
0.086
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.086
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.085
|
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.085
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.085
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.084
|
|
|
|
metanephric thick ascending limb development
|
GO:0072233 |
2 |
0.083
|
|
|
|
regulation of branching involved in ureteric bud morphogenesis
|
GO:0090189 |
22 |
0.083
|
|
|
|
metanephric proximal straight tubule development
|
GO:0072230 |
1 |
0.083
|
|
|
|
ovulation
|
GO:0030728 |
15 |
0.082
|
|
|
|
cellular response to corticosteroid stimulus
|
GO:0071384 |
13 |
0.082
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.081
|
|
|
|
acidic amino acid transport
|
GO:0015800 |
16 |
0.081
|
|
|
|
chloride transmembrane transport
|
GO:1902476 |
24 |
0.081
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.080
|
|
|
|
l alpha amino acid transmembrane transport
|
GO:1902475 |
23 |
0.080
|
|
|
|
regulation of potassium ion transmembrane transporter activity
|
GO:1901016 |
7 |
0.080
|
|
|
|
regulation of gluconeogenesis
|
GO:0006111 |
30 |
0.079
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.079
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.079
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.078
|
|
|
|
l glutamate import into cell
|
GO:1990123 |
3 |
0.078
|
|
|
|
dopamine metabolic process
|
GO:0042417 |
23 |
0.078
|
|
|
|
insulin receptor signaling pathway
|
GO:0008286 |
49 |
0.078
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.077
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.077
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.077
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.077
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.076
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.076
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.074
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.074
|
|
|
|
positive regulation of branching involved in ureteric bud morphogenesis
|
GO:0090190 |
18 |
0.074
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.074
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.073
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.073
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.072
|
|
|
|
vasodilation by angiotensin involved in regulation of systemic arterial blood pressure
|
GO:0002033 |
2 |
0.072
|
|
|
|
positive regulation of insulin receptor signaling pathway
|
GO:0046628 |
4 |
0.072
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.072
|
|
|
|
steroid catabolic process
|
GO:0006706 |
7 |
0.071
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.071
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.070
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.070
|
|
|
|
metanephric nephron tubule development
|
GO:0072234 |
16 |
0.069
|
|
|
|
regulation of appetite
|
GO:0032098 |
12 |
0.069
|
|
|
|
regulation of camp biosynthetic process
|
GO:0030817 |
25 |
0.068
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.068
|
|
|
|
protein kinase c signaling
|
GO:0070528 |
7 |
0.068
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.068
|
|
|
|
cell proliferation in hindbrain
|
GO:0021534 |
10 |
0.068
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.067
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.067
|
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.067
|
|
|
|
multicellular organismal water homeostasis
|
GO:0050891 |
23 |
0.067
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.067
|
|
|
|
memory
|
GO:0007613 |
58 |
0.066
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.066
|
|
|
|
calcium independent cell cell adhesion via plasma membrane cell adhesion molecules
|
GO:0016338 |
4 |
0.066
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.066
|
|
|
|
metanephric nephron epithelium development
|
GO:0072243 |
19 |
0.065
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.065
|
|
|
|
metanephric epithelium development
|
GO:0072207 |
21 |
0.065
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.065
|
|
|
|
response to activity
|
GO:0014823 |
13 |
0.065
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.064
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.064
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.064
|
|
|
|
ovulation from ovarian follicle
|
GO:0001542 |
9 |
0.063
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.063
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.062
|
|
|
|
cellular response to glucocorticoid stimulus
|
GO:0071385 |
13 |
0.062
|
|
|
|
cell cell adhesion via plasma membrane adhesion molecules
|
GO:0098742 |
40 |
0.062
|
|
|
|
cellular response to vitamin d
|
GO:0071305 |
2 |
0.062
|
|
|
|
regulation of serotonin uptake
|
GO:0051611 |
2 |
0.061
|
|
|
|
progesterone biosynthetic process
|
GO:0006701 |
1 |
0.061
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.061
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.061
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.060
|
|
|
|
regulation of circadian sleep wake cycle
|
GO:0042749 |
3 |
0.060
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.060
|
|
|
|
cellular response to temperature stimulus
|
GO:0071502 |
2 |
0.059
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.058
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.058
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.058
|
|
|
|
acid secretion
|
GO:0046717 |
33 |
0.057
|
|
|
|
positive regulation of the force of heart contraction by epinephrine norepinephrine
|
GO:0001997 |
3 |
0.057
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.057
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.057
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.057
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.056
|
|
|
|
regulation of ph
|
GO:0006885 |
26 |
0.056
|
|
|
|
cellular response to fructose stimulus
|
GO:0071332 |
2 |
0.056
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.056
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.055
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.055
|
|
|
|
establishment of blood nerve barrier
|
GO:0008065 |
3 |
0.055
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.055
|
|
|
|
positive regulation of mesonephros development
|
GO:0061213 |
20 |
0.055
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.054
|
|
|
|
cardiac muscle hypertrophy
|
GO:0003300 |
23 |
0.054
|
|
|
|
negative regulation of muscle contraction
|
GO:0045932 |
12 |
0.054
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.054
|
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
26 |
0.054
|
|
|
|
exploration behavior
|
GO:0035640 |
21 |
0.054
|
|
|
|
cellular response to ketone
|
GO:1901655 |
12 |
0.053
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.053
|
|
|
|
positive regulation of nitric oxide biosynthetic process
|
GO:0045429 |
14 |
0.053
|
|
|
|
cellular response to hexose stimulus
|
GO:0071331 |
47 |
0.053
|
|
|
|
gastric acid secretion
|
GO:0001696 |
6 |
0.052
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
52 |
0.052
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.052
|
|
|
|
phospholipase c activating angiotensin activated signaling pathway
|
GO:0086097 |
1 |
0.052
|
|
|
|
regulation of blood vessel size by renin angiotensin
|
GO:0002034 |
5 |
0.052
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.051
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.051
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.051
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.051
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.051
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.050
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.050
|
|
|
|
positive regulation of glycolytic process
|
GO:0045821 |
4 |
0.050
|
|
|
|
phospholipase c activating dopamine receptor signaling pathway
|
GO:0060158 |
5 |
0.050
|
|
|
|
catecholamine metabolic process
|
GO:0006584 |
30 |
0.049
|
|
|
|
response to fructose
|
GO:0009750 |
2 |
0.049
|
|
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.049
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.049
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.049
|
|
|
|
mineralocorticoid metabolic process
|
GO:0008212 |
2 |
0.048
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.047
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway
|
GO:2001238 |
34 |
0.047
|
|